...BRCA1/2 mutation testing. This is a critical component of the evidence base needed when considering implementation of fa...
The contribution of BRCA1 and BRCA2 to breast cancer incidence in Cuba has not yet been explored. In order to estimate t...
...BRCA1, BRCA2, PALB2, CHEK2 and BRIP1. RAP80 works upstream of BRCA1 and is essential for the localization of BRCA1 to th...
...BRCA1/2-negative Spanish breast cancer families. We also performed an exhaustive screening of three previously described...
We screened BRCA1 and BRCA2 germline mutations in 60 high-risk breast and/or ovarian cancer patients and 20 relatives fr...
...BRCA1 predispose to breast cancer. CTIP interacts with BRCA1 and so could also be associated with increased risk. We scr...
...Brca1, these two models did not result in any observable changes in the mammary gland. Our results suggest that BRCA1-as...
...BRCA1 or BRCA2, or with no BRCA1/2 mutations (BRCAX). Genes discriminating between BRCA1, BRCA2 or BRCAX and controls we...
...BRCA1/2 mutation status. To date, 44 different BRCA1/2 variants have been identified in 55 HBOC families. Of the seven n...
...BRCA1 and/or 2 genes, and to predict the risk of developing breast cancer. The COS model was developed from the better-k...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
